Molecular Diagnosis & Therapy

Papers
(The H4-Index of Molecular Diagnosis & Therapy is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects152
ADORA3: A Key Player in the Pathogenesis of Intracranial Aneurysms and a Potential Diagnostic Biomarker100
The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy: A Systematic Review85
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors69
Comment on “Prognostic and Clinical Significance of Human Leukocyte Antigen Class I Expression in Breast Cancer: A Meta‑Analysis”68
A Window of Opportunity for Newborn Screening54
Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate52
Molecular Therapy for Choroideremia: Pre-clinical and Clinical Progress to Date47
Personalized Cancer Monitoring Assay for the Detection of ctDNA in Patients with Solid Tumors40
Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target39
Personalized Medicine in Cystic Fibrosis: Characterization of Eight Rare CFTR Variants in Intestinal Organoids and Cellular Models38
Evaluation of Minimal Residual Disease in Patients with Neuroblastoma37
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?33
Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights30
Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk29
Research Progress on Signal Conversion Based on Aptamer Combined CRISPR/Cas System in Biosensors28
Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach26
Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges23
Advances and Challenges in the Diagnosis of Leishmaniasis23
Personalizing Oncolytic Immunovirotherapy Approaches22
Afamitresgene Autoleucel: First Approval21
Inflammatory Gene Panel Guiding the Study of Genetics in Inflammatory Bowel Disease21
0.83623695373535